LY254155 is an antifolate agent used for its potent inhibitory activity against human glycinamide ribonucleotide formyltransferase (hGARFT) and its high-affinity binding to membrane folate-binding protein (mFBP); it demonstrates significant antitumor activity in a broad panel of murine and human xenograft solid tumor models, effectively inhibiting tumor growth in vivo.